AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Convatec Group PLC

Director's Dealing Mar 23, 2022

4959_dirs_2022-03-23_49a2845b-d4a1-4f05-9d9a-e7b988772a49.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 7623F

ConvaTec Group PLC

23 March 2022

23 March 2022

ConvaTec Group Plc

("ConvaTec" or "the Company")

Director/PDMR Shareholding

The Company has been notified of the following transaction by a Person Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").

On 22 March 2022, Kim Lody, Non-Executive Director and PDMR, purchased 10,000 Shares at £2.04 per Share. Kim Lody's resulting shareholding is 10,000 Shares.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Kim Lody
2 Reason for the notification
a) Position/Status Non-Executive Director
b) Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name ConvaTec Group Plc
b) LEI 213800LS272L4FIDOH92
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Identification code
Ordinary shares of 10p each in ConvaTec Group Plc ("Shares")

GB00BD3VFW73
b) Nature of the transaction Purchase of shares on 22 March 2022
c) Price(s) and volume(s) Price(s)

£2.04
Volume(s)

10,000
d) Aggregated information

- Aggregated volume 

- Price
10,000

£20,400
e) Date of the transaction 2022-03-22
f) Place of the transaction London Stock Exchange, Main Market (XLON)

Enquiries

Analysts and Investors

Kate Postans, VP Investor Relations, ConvaTec                      +44 (0)782 644 7807

[email protected]

Media

Buchanan: Charles Ryland / Chris Lane                                      +44 (0)207 466 5000                                                                                                                     

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on solutions for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFFLVFIVFIF

Talk to a Data Expert

Have a question? We'll get back to you promptly.